Exact Mass: 337.1379

Exact Mass Matches: 337.1379

Found 25 metabolites which its exact mass value is equals to given mass value 337.1379, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Streptobiosamine

Streptobiosamine

C13H23NO9 (337.1373)


An amino disaccharide that is a 2-deoxy-2-(methylamino)-alpha-L-glucopyranose ring joined to a L-lyxose with a formyl substituent at position 3.

   

4-O-alpha-D-Galactopyranosylcalystegine B2

4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,3-triol

C13H23NO9 (337.1373)


4-O-alpha-D-Galactopyranosylcalystegine B2 is found in fruits. 4-O-alpha-D-Galactopyranosylcalystegine B2 is an alkaloid from the fruit of Morus alba (white mulberry). Alkaloid from the fruit of Morus alba (white mulberry). 4-O-alpha-D-Galactopyranosylcalystegine B2 is found in fruits.

   

6-oxo-famciclovir

2-[(acetyloxy)methyl]-4-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)butyl acetate

C14H19N5O5 (337.1386)


6-oxo-famciclovir is a metabolite of famciclovir. Famciclovir is a guanine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir. On August 24, 2007, the United States Food and Drug Administration approved the first generic version of famciclovir. (Wikipedia)

   

N(6)-Monobutyryladenosine

N-{9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}butanamide

C14H19N5O5 (337.1386)


   
   
   
   

2-O-Methyl-b-D-N-acetylneuraminic acid methyl ester

2-O-Methyl-b-D-N-acetylneuraminic acid methyl ester

C13H23NO9 (337.1373)


   

SCHEMBL4265170

SCHEMBL4265170

C13H23NO9 (337.1373)


   

N2-Isobutyryl-2-deoxyguanosine

N2-Isobutyryl-2-deoxyguanosine

C14H19N5O5 (337.1386)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.589 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.591 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.583 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.587

   

N2-Isobutyl-deoxyguanosine

N2-Isobutyl-deoxyguanosine

C14H19N5O5 (337.1386)


   

N2-(S)-Propano-deoxyguanosine

N2-(S)-Propano-deoxyguanosine

C14H19N5O5 (337.1386)


   

N2-(R)-Propano-deoxyguanosine

N2-(R)-Propano-deoxyguanosine

C14H19N5O5 (337.1386)


   

4-O-a-D-Galactopyranosylcalystegine b2

4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,3-triol

C13H23NO9 (337.1373)


   
   

Tecadenoson

Tecadenoson

C14H19N5O5 (337.1386)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent Tecadenoson (CVT-510) is a selective A1 adenosine receptor agonist. Tecadenoson (CVT-510) is a selective A1 adenosine receptor agonist.

   

6-oxo-famciclovir

6-oxo-famciclovir

C14H19N5O5 (337.1386)


   

Cyclic 1,N(2)-propanodeoxyguanosine

Cyclic 1,N(2)-propanodeoxyguanosine

C14H19N5O5 (337.1386)


   

ethyl N-acetylneuraminate

ethyl N-acetylneuraminate

C13H23NO9 (337.1373)


   

4-O-alpha-D-Galactopyranosylcalystegine B2

4-O-alpha-D-Galactopyranosylcalystegine B2

C13H23NO9 (337.1373)


   

1-[(1s,2r)-1-amino-2-{[(1r,2s)-2-amino-1-hydroxy-2-(4-oxopyridin-1-yl)ethyl](hydroxy)amino}-2-hydroxyethyl]pyridin-4-one

1-[(1s,2r)-1-amino-2-{[(1r,2s)-2-amino-1-hydroxy-2-(4-oxopyridin-1-yl)ethyl](hydroxy)amino}-2-hydroxyethyl]pyridin-4-one

C14H19N5O5 (337.1386)


   

(1r,2s,3r,5s,6r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,6-triol

(1r,2s,3r,5s,6r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,6-triol

C13H23NO9 (337.1373)


   

1-(1-amino-2-{[2-amino-1-hydroxy-2-(4-oxopyridin-1-yl)ethyl](hydroxy)amino}-2-hydroxyethyl)pyridin-4-one

1-(1-amino-2-{[2-amino-1-hydroxy-2-(4-oxopyridin-1-yl)ethyl](hydroxy)amino}-2-hydroxyethyl)pyridin-4-one

C14H19N5O5 (337.1386)


   

3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,6-triol

3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,6-triol

C13H23NO9 (337.1373)